Results 121 to 130 of about 7,921 (224)
ABSTRACT Fatty acid hydroxylase‐associated neurodegeneration (FAHN) is an ultra‐rare neurological disorder caused by a mutation in the FA2H gene. Defective production of this gene leads to abnormal myelin formation, which subsequently causes neurodegeneration and brain iron accumulation.
Araj Naveed Siddiqui +4 more
wiley +1 more source
Frontal Lobe Epilepsy Presenting With Unilateral Eye Closure
Neurology and Clinical Neuroscience, EarlyView.
Yuki Mizumoto +6 more
wiley +1 more source
ABSTRACT This report describes a 7‐year‐old boy with MOGAD presenting as severe ADEM with fever, encephalopathy, seizures, markedly elevated intracranial pressure, diffuse multifocal MRI abnormalities, and serum MOG‐IgG positivity. He required intravenous corticosteroids, plasma exchange, IVIG, and tocilizumab, followed by rehabilitation and ...
Desiree‐Anne Ramsaran +2 more
wiley +1 more source
ABSTRACT There are limited reports on vagus nerve stimulation (VNS) therapy during pregnancy. We report a case of two pregnancies in a woman with drug‐resistant epilepsy (DRE) managed with VNS. A woman with epilepsy underwent implantation of a VNS device because antiseizure medications (ASMs) and a lobectomy were not sufficient to control seizures ...
Motoki Ono +5 more
wiley +1 more source
Breath Signatures of Antiseizure Medication Response and Tolerability in Adults With Epilepsy
Breath metabolomic profiles distinguish treatment response and adverse effects in adults with epilepsy, whereas serum antiseizure medication concentrations do not. These findings support breath analysis as a non‐invasive approach to pharmacodynamic phenotyping, capturing treatment‐related metabolic states relevant to complex human disease.
Kai Fricke +11 more
wiley +1 more source
Background/Objectives: Epilepsy is identified by irregular neuronal hyperexcitability, generating recurrent seizures. Despite many available pharmacological treatments, certain patients with drug-resistant epilepsy may require novel therapeutic ...
Ioannis Dardalas +7 more
doaj +1 more source
E, A/0000-0003-3698-8201WOS: 000408852700005Objectives: Lacosamide is a novel antiepileptic drug used in partial refractory epilepsy patients. Methods: We searched retrospectively 1100 patients who have follow up in Antalya Education and Research ...
Kutlu, Gulnihal +6 more
core +1 more source
Cenobamate use in super‐refractory status epilepticus: A report of three cases
Abstract Objectives Super‐refractory status epilepticus (SRSE) is a neurological emergency with high morbidity and mortality. Cenobamate, a novel antiseizure medication, may be helpful in managing SRSE, but evidence is limited. Methods This retrospective case series reports the use of cenobamate as add‐on therapy in the management of three cases of ...
Marina Romozzi +11 more
wiley +1 more source

